Analyst consensus rating
CareDx Analyst Rating: Buy
Direct answer
CareDx's consensus rating is Buy.
6 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $93.50.
Forecast evidence checked November 3, 2026.
Get free CareDx email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $85.88
- Average price target
- $93.50
- High price target
- $100.00
- Low price target
- $90.00
- Low target gap
- +4.8%
- Target upside
- +8.9%
- High target gap
- +16.4%
- Target range width
- 11.6%
- Consensus rating
- Buy
- Analysts
- 6
- Evidence date
- November 3, 2026
- Valid through
- November 10, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for CareDx?
CareDx has a verified Buy consensus. The same dataset has an average price target of $93.50.
How far are CareDx's low and high targets from the recorded price?
The low target implies +4.8%, while the high target implies +16.4%.
How many analysts are included in CareDx's consensus?
The verified consensus includes 6 analysts.
How is CareDx's target upside or downside calculated?
The average target of $93.50 is divided by the recorded price of $85.88, then one is subtracted to produce +8.9%. This does not guarantee a future return.
When was CareDx's analyst forecast verified?
The data was verified on 2026-11-03. The dataset is valid through 2026-11-10.